Back to
BARCLAYS PLC
XBI31 quarters
Position history for
BARCLAYS PLC's holdings in State Street SPDR SP Biotech ETF
Yes. Barclays holds 2,817,943 shares of XBI (State Street SPDR SP Biotech ETF), worth $445.9M, as of its Q2 2026 13F filing. It reduced the position by 16,217 shares (-0.6%) from Q1 2026. Barclays has held XBI in every 13F on record since Q4 2018, 31 quarterly filings. XBI is 0.1% of Barclays' reported 13F portfolio.
Current Value
$445.9M
Current Shares
2.8M
Total Value Change
+$393.5M
Total Shares Change
+2.1M
Quarter-by-Quarter History
Other major holders of XBI: BNP PARIBAS FINANCIAL MARKETS, GOLDMAN SACHS GROUP INC